# Retraction: Overexpression of the Long Noncoding RNA FOXD2-AS1 Promotes Cisplatin Resistance in Esophageal Squamous Cell Carcinoma Through the miR-195/Akt/mTOR Axis

PMC · DOI: 10.32604/or.2024.062048 · Oncology Research · 2025-05-29

## Full-text entities

- **Genes:** FOXD2-AS1 (FOXD2 adjacent opposite strand RNA 1) [NCBI Gene 84793], AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, MIR195 (microRNA 195) [NCBI Gene 406971] {aka MIRN195, miRNA195, mir-195}
- **Diseases:** Esophageal Squamous Cell Carcinoma (MESH:D000077277)
- **Chemicals:** Cisplatin (MESH:D002945)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12144606/full.md

---
Source: https://tomesphere.com/paper/PMC12144606